Read + Share
Amedeo Smart
Independent Medical Education
Shaw CA, Essink B, Harper C, Mithani R, et al. Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase I Clinical Trial in Healthy Older Adults. J Infect Dis 2024 Feb 22:jiae081. doi: 10.1093.PMID: 38385566
Email
LinkedIn
Facebook
Twitter
Privacy Policy